{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:28:19Z","timestamp":1791149299514,"version":"4.1.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","lipidjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.jacl.2014.08.010","type":"journal-article","created":{"date-parts":[[2014,9,9]],"date-time":"2014-09-09T09:17:25Z","timestamp":1410254245000},"page":"635-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1"],"prefix":"10.1016","volume":"8","author":[{"given":"Zahid","family":"Ahmad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don P.","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacl.2014.08.010_bib1","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1056\/NEJMcp070061","article-title":"Clinical practice. Hypertriglyceridemia","volume":"357","author":"Brunzell","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2014.08.010_bib2","first-page":"2134","article-title":"Clinical assessment of hyperlipidemic pancreatitis","volume":"90","author":"Fortson","year":"1995","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2014.08.010_bib3","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1111\/j.1572-0241.2006.00856.x","article-title":"Practice guidelines in acute pancreatitis","volume":"101","author":"Banks","year":"2006","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2014.08.010_bib4","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1046\/j.0007-1323.2001.01813.x","article-title":"Late mortality in patients with severe acute pancreatitis","volume":"88","author":"Gloor","year":"2001","journal-title":"Br J Surg"},{"key":"10.1016\/j.jacl.2014.08.010_bib5","first-page":"591","article-title":"Pancreatitis in children","volume":"37","author":"Werlin","year":"2003","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/j.jacl.2014.08.010_bib6","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.1111\/j.1572-0241.2002.05833.x","article-title":"Acute pancreatitis in children","volume":"97","author":"DeBanto","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacl.2014.08.010_bib7","series-title":"Chapter 117: Familial Lipoprotein Lipase Deficiency, Apo C-II Deficiency, and Hepatic Lipase Deficiency. Metabolic and Molecular Bases of Inherited Disease","author":"Deep","year":"2006"},{"key":"10.1016\/j.jacl.2014.08.010_bib8","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1365-2796.2007.01912.x","article-title":"Hypertriglyceridaemia and low plasma HDL in a patient with apolipoprotein A-V deficiency due to a novel mutation in the APOA5 gene","volume":"263","author":"Priore Oliva","year":"2008","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2014.08.010_bib9","doi-asserted-by":"crossref","first-page":"2862","DOI":"10.1172\/JCI24471","article-title":"Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment","volume":"115","author":"Marcais","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/j.jacl.2014.08.010_bib10","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1038\/ng.2007.24","article-title":"Mutations in LMF1 cause combined lipase deficiency and severe hypertriglyceridemia","volume":"39","author":"Peterfy","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/j.jacl.2014.08.010_bib11","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1161\/ATVBAHA.109.186577","article-title":"Chylomicronemia With a Mutant GPIHBP1 (Q115P) That Cannot Bind Lipoprotein Lipase","volume":"29","author":"Beigneux","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2014.08.010_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1111\/joim.12003","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 and the intravascular processing of triglyceride-rich lipoproteins","volume":"272","author":"Adeyo","year":"2012","journal-title":"J Intern Med"},{"key":"10.1016\/j.jacl.2014.08.010_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.cmet.2010.04.016","article-title":"GPIHBP1 is responsible for the entry of lipoprotein lipase into capillaries","volume":"12","author":"Davies","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacl.2014.08.010_bib14","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.cmet.2007.02.002","article-title":"Glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 plays a critical role in the lipolytic processing of chylomicrons","volume":"5","author":"Beigneux","year":"2007","journal-title":"Cell metabolism"},{"key":"10.1016\/j.jacl.2014.08.010_bib15","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s10545-011-9406-5","article-title":"Deletion of GPIHBP1 causing severe chylomicronemia","volume":"35","author":"Rios","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/j.jacl.2014.08.010_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jacl.2014.02.006","article-title":"Genotype-phenotype relationships in patients with type I hyperlipoproteinemia","volume":"8","author":"Chokshi","year":"2014","journal-title":"J\u00a0Clin Lipidol"},{"key":"10.1016\/j.jacl.2014.08.010_bib17","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1093\/ajcn\/36.5.950","article-title":"Medium-chain triglycerides: an update","volume":"36","author":"Bach","year":"1982","journal-title":"Am J\u00a0Clin Nutr"},{"key":"10.1016\/j.jacl.2014.08.010_bib18","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1093\/ajcn\/44.5.630","article-title":"Thermic effect of medium-chain and long-chain triglycerides in man","volume":"44","author":"Seaton","year":"1986","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.jacl.2014.08.010_bib19","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/014860719101500127","article-title":"Thermogenesis from intravenous medium-chain triglycerides","volume":"15","author":"Mascioli","year":"1991","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/j.jacl.2014.08.010_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/BF02544586","article-title":"Serum fatty acid profiles after intravenous medium chain triglyceride administration","volume":"24","author":"Mascioli","year":"1989","journal-title":"Lipids"},{"key":"10.1016\/j.jacl.2014.08.010_bib21","doi-asserted-by":"crossref","first-page":"3313","DOI":"10.1210\/jc.2011-1159","article-title":"Clinical review#: Lipodystrophies: genetic and acquired body fat disorders","volume":"96","author":"Garg","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jacl.2014.08.010_bib22","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1056\/NEJMra012577","article-title":"Ethical, legal, and social implications of genomic medicine","volume":"349","author":"Clayton","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2014.08.010_bib23","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jacl.2014.08.010_bib24","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/gt.2012.43","article-title":"Efficacy and long-term safety of alipogene tiparvovec (AAV1-LPL(S447X)) gene therapy for lipoprotein lipase deficiency: an open-label trial","volume":"20","author":"Gaudet","year":"2013","journal-title":"Gene Ther"},{"key":"10.1016\/j.jacl.2014.08.010_bib25","doi-asserted-by":"crossref","first-page":"2303","DOI":"10.1161\/ATVBAHA.108.175620","article-title":"Intramuscular administration of AAV1-lipoprotein lipase S447X lowers triglycerides in lipoprotein lipase-deficient patients","volume":"28","author":"Stroes","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.jacl.2014.08.010_bib26","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/S0022-3476(98)70280-X","article-title":"Familial lipoprotein lipase deficiency in infancy: clinical, biochemical, and molecular study","volume":"133","author":"Feoli-Fonseca","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/j.jacl.2014.08.010_bib27","series-title":"Johns Hopkins Textbook of Dyslipidemia","article-title":"Fish Oils in the Treatment of Dyslipidemia and Cardiovascular Disease","author":"Harold Bays","year":"2010"},{"key":"10.1016\/j.jacl.2014.08.010_bib28","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1080\/07315724.1998.10718794","article-title":"Insulin therapy for a non-diabetic patient with severe hypertriglyceridemia","volume":"17","author":"Jabbar","year":"1998","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/j.jacl.2014.08.010_bib29","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/j.annfar.2004.06.006","volume":"23","author":"Sleth","year":"2004","journal-title":"Annales francaises d'anesthesie et de reanimation"},{"key":"10.1016\/j.jacl.2014.08.010_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S0002-9149(01)02208-1","article-title":"Usefulness of Orlistat in the treatment of severe hypertriglyceridemia","volume":"89","author":"Wierzbicki","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.jacl.2014.08.010_bib31","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.jacl.2012.11.006","article-title":"Lipoprotein abnormalities in compound heterozygous lipoprotein lipase deficiency after treatment with a low-fat diet and orlistat","volume":"7","author":"Blackett","year":"2013","journal-title":"J Clin Lipidol"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414003146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287414003146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T13:33:39Z","timestamp":1761831219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287414003146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1933287414003146"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2014.08.010","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial chylomicronemia syndrome and response to medium-chain triglyceride therapy in an infant with novel mutations in GPIHBP1","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2014.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 National Lipid Association. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}